Rev 4/2010 CURRICULUM VITAE Name: Patrick Mahlen O'Neil Birth Date: January 13, 1948 Home Address: 1738 Thompson Avenue Phone: 843-883-9266 Sullivan’s Island, SC 29482 Office Address: Medical University of South Carolina, Institute of Psychiatry Phone: 843- 792-2273 Weight Management Center, Suite 410 South Fax: 843-792- 5432 67 President Street Charleston, SC 29425 Citizenship and/or Visa Information: U.S. Citizen Education: Institution/Location Years Degree/Date Field of Study Louisiana State University 1965–1971 B.S./1970 Major: Economics; Undergraduate Baton Rouge work in Psychology: 1970–1971 University of Georgia 1971–1975 M.S./1973 Major: Psychology Athens, Georgia Ph.D./1975 Major: Clinical Psychology Co-Major: Organizational Management Internship: Clinical Psychology Intern September 1973–August 1974 Veterans Administration Hospital and Medical University of South Carolina Residencies or Post Doctoral: Postdoctoral Fellow in Clinical Psychology September 1975–February 1977 Dept. of Psychiatry and Behavioral Sciences, Medical University of South Carolina Specialty/Board Certification: Licensure: Clinical Psychologist, State of South Carolina, #192, 1975- Present 1
53
Embed
An up-to-date curriculum vitae utilizing the College of Medicine ...
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Rev 4/2010CURRICULUM VITAE
Name: Patrick Mahlen O'Neil Birth Date: January 13, 1948
Home Address: 1738 Thompson Avenue Phone: 843-883-9266Sullivan’s Island, SC 29482
Office Address: Medical University of South Carolina, Institute of Psychiatry Phone: 843-792-2273
Weight Management Center, Suite 410 South Fax: 843-792-5432
67 President Street Charleston, SC 29425
Citizenship and/or Visa Information: U.S. Citizen
Education:Institution/Location Years Degree/Date Field of StudyLouisiana State University 1965–1971 B.S./1970 Major: Economics; Undergraduate Baton Rouge work in Psychology: 1970–1971
University of Georgia 1971–1975 M.S./1973 Major: PsychologyAthens, Georgia Ph.D./1975 Major: Clinical Psychology
Co-Major: Organizational Management
Internship:Clinical Psychology Intern September 1973–August 1974Veterans Administration Hospital and Medical University of South Carolina
Residencies or Post Doctoral:Postdoctoral Fellow in Clinical PsychologySeptember 1975–February 1977Dept. of Psychiatry and Behavioral Sciences,Medical University of South Carolina
Specialty/Board Certification:
Licensure: Clinical Psychologist, State of South Carolina, #192, 1975- Present
Other Licenses and Credentials:Certified Clinical Trial Investigator (Association of Clinical Research
Professionals), 2008-Present
Notary Public, State of South Carolina, 2006-2016OUPV-Operator Of Uninspected Passenger Vessels As Defined In 46 U.S.C. 2101 (42)(B)
Upon Near Coastal Waters Not More than 100 Miles Offshore, United States Coast Guard License, 2009-2014
1
Faculty Appointments: Years Rank Institution Department1977 Research Associate Medical University of Psychiatry and
South Carolina Behavioral Sciences
1977–1978 Research Psychologist Veterans Administration Hospital
1977–1983 Assistant Professor Medical University of Psychiatry and
South Carolina Behavioral Sciences
1983–1994 Associate Professor Medical University of Psychiatry and South Carolina Behavioral Sciences
1994–Present Professor Medical University of Psychiatry ofSouth Carolina Behavioral Sciences
2009-Present Professor Medical University of SurgerySouth Carolina
Administrative Appointments:Years Position Institution Department1984–Present Director Medical University Psychiatry and
of South Carolina Behavioral Sciences/ Weight Management
Center
1992–1994 Associate Director Medical University Psychiatry of For Clinical Training of South Carolina Behavioral Sciences
Hospital Appointments/Privileges:Years Active/Inactive Institution1978–Present Active MUSC Medical Center
Other Experience:Years Position Institution Department1971–1972 Teaching Assistant University of Georgia Psychology
1972–1973 Institution CounselorTerrebonne RegionalMental Health Center
1972–1973 Research Assistant University of Georgia Psychology
1974 Part-time Instructor Baptist College Psychology
1974–1975 Research Assistant University of Georgia Psychology
1974–1975 Clinical Practicum University of Georgia PsychologyTeam Leader
1976 Part-time Instructor The Citadel Psychology of
2
Exceptional Children
1978–1981 Co-Organizer; South Carolina SchoolAnnual Advanced of Alcohol and Drug Workshops for StudiesHealth- Care Professionals
1979–1981 Curriculum South Carolina School Committee of Alcohol and Drug
Studies
1981 Instructor Medical University Psychiatry and of South Carolina Behavioral Sciences
Membership in professional/scientific societies:Association for Advancement of Behavior Therapy
Chair, Obesity and Eating Disorders Special Interest Group, 1985–1988
The Obesity Society (Formerly North American Association for the Study of Obesity)
Education Committee, 1994–2001: Chair, 2006-2008Abstract Review Committee, 1997 Program Chair and Local Arrangements Coordinator, 1999 Annual Meeting Ad hoc committee to prepare Practical Guidelines translation booklet of NIH
“Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults” for widespread dissemination to physicians and other health care providers, 1998–2000
Web site Editor, 2000–2004 Publications Committee, 2001–2004Member of Council, 2006–2009Vice-President, 2009-2010
SC Academy of Professional Psychologists President-Elect, 1997 President, 1998
South Carolina Psychological Association Member, Executive Council, 1997
Obesity Research NetworkInvestigator member, 1996–Present
South Carolina Obesity Advisory Committee, DHECMember, 1999
Committee on Military Nutrition Research, Food and Nutrition Board, Institute of Medicine
Member, 2001–2006
Editorial Positions:2000–Present Editorial Board, Eating Behaviors: An International Journal2005–Present Associate Editor, Surgery for Obesity and Related Diseases
3
2005–Present Editorial Board, International Journal of Obesity2008–Present Editorial Board, Obesity
Guest Reviewer:Behavior Modification, 1978Journal of Behavioral Assessment, 1979–1981, 1984–1985, 1989British Journal of Social Psychology, 1989Journal of Psychopathology and Behavioral Assessment, 1990–PresentArchives of Dermatology, 1991Women & Health, 1991Cognitive Therapy and Research, 1992Applied & Preventive Psychology: Current Scientific Perspectives, 1993American Journal of Clinical Nutrition, 1994–1995, 1997Journal of Abnormal Psychology, 1994Obesity (formerly Obesity Research), 1996–PresentInternational Journal of Obesity, 1999–2004Journal of Women’s Health and Gender-Based Medicine, 2000–2006American Journal of Psychiatry, 2001–present
Extramural Grants/award amount (current and past):As Principal Investigator:
Past:O’Neil PM (Principal Investigator). Developmental funding for the Weight
Management Center. Funded by Fullerton Foundation, $118,000; 1984.
O’Neil PM (Principal Investigator). A 52-Week Study of the Weight Loss Maintenance Effect of Orlistat in the Treatment of Obesity after a 24-Week Period of Weight Loss by Conventional Diet Therapy. Funded by Hoffmann-La Roche, Inc., $778,592; 1993.
O’Neil PM (Principal Investigator). Characterization of Serum Leptin Concentrations in the General Adult Population. Funded by Amgen, Inc., $20,280; 1995.
O’Neil PM (Principal Investigator). Egan B (Co-Investigator). A Fifty-Two Week, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Study to Compare the Effects of Sibutramine Hydrochloride 20 mg with Those of Placebo in Mild to Moderate Obese Patients whose Hypertension is Controlled by a Calcium-Channel Blocker, with or without Concomitant Thiazide Diuretic Therapy. Funded by Knoll Pharmaceutical Company (BASF Pharma), $184,266; 1995.
O’Neil PM (Principal Investigator). A Study to Evaluate the Safety and Efficacy of Varying Dosages of Timed Medications in the Treatment of Obesity. Funded by Ergo Science Development Corporation, $213,708; 1997.
O’Neil PM (Principal Investigator). Follow-up Health Outcomes of Xenical Patients. Funded by Hoffman La Roche, Inc., $7,995; 1997. Supplemental funding of $7,011.
O’Neil PM (Principal Investigator). A Phase II Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Weight Loss Effects of Recombinant-Methionyl
4
Human Leptin (r-met Huleptin) in Obese Subjects Stratified by Weight Loss After Induction with R-Met Huleptin. Funded by Amgen, Inc., $384,612; 1997.
O’Neil PM (Principal Investigator). A Follow-up Study to Assess the Long Term Safety and Tolerability of Leptin in the Treatment of Uncomplicated Obesity. Funded by Amgen, Inc., $180,348; 1998.
O’Neil PM (Principal Investigator). 52 Week, Efficacy of Orlistat Treatment plus Diet in Obese Type 2 Diabetic Patients Receiving Metformin. Funded by Innovex, $60,700; 1998.
O’Neil PM (Principal Investigator). Psychological and Behavioral Factors Associated with Leptin Treatment and Response. Supplemental funding by Amgen, Inc., $5,735; 1998.
O’Neil PM (Principal Investigator). A Follow-up Open Label Study to Assess the Long Term Safety and Tolerability of Leptin (r-met HuLeptin) in the Treatment of Uncomplicated Obesity. Funded by Amgen, Inc., $181,848; 1998.
O’Neil PM (Principal Investigator). Daily Subcutaneous Administration of A-100 in Obese Subjects. Funded by Amgen, Inc., $167,009; 1999.
O’Neil PM (Principal Investigator). A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Tolerability and Efficacy of Oral 1555U88 (2.5 mg, 5 mg, 10 mg, or 15 mg per day) Compared to Placebo for the Treatment of Obesity in Subjects 18–65 Years of Age. Funded by Glaxo-Wellcome, $233,158; 1999.
O’Neil PM (Principal Investigator). Tolerability and Efficacy of Oral 1555U88 Compared to Placebo for the Treatment of Obesity in Subjects 18-65 Years of Age. Funded by Glaxo Wellcome, $229, 658; 2000.
O’Neil PM (Principal Investigator). A Phase III Multi-Center, Two-Arm Study to Assess the Efficacy and Safety of Ecopipam (SCH 39166) in the Management of Obesity. Funded by Schering-Plough Research Institute, $519,552; 2000.
O’Neil PM (Principal Investigator). A 24-Week, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel Group-Study to Investigate the Efficacy and Tolerability of 300 mg/day and 400 mg/day of Bupropion SR Compared to Placebo for the Treatment of Obesity with a 24-Week Open-Label Extension. Funded by Obesity Research Network, $213,365; 2000.
O’Neil PM (Principal Investigator). A Randomized, Double-Blind, Placebo-Controlled Multicenter, Parallel Group, Dose-Response Study to Assess the Efficacy and Safety of Topiramate in the Treatment of Subjects with Diabetes. Funded by Parexel International Corporation, $174,175; 2000.
O’Neil PM (Principal Investigator). A Double-Blind, Placebo-Controlled, 52-Week Study of the Efficacy and Tolerability of Xenical (Orlistat) in the Weight Management of Obese Pediatric Patients. Funded by Hoffmann-La Roche, Inc., $318,412; 2000.
O’Neil PM (Principal Investigator). A Randomized, Double Blind, Placebo-Controlled, Parallel Group, Fixed-Dose, Multi-Center Study of Weight Reducing and Prevention of Weight Regain Effects and Safety of SR141716 in Obese
5
Patients with or without Comorbidities. Funded by Icon Clinical Research, Inc., $618,268; 2001.
O’Neil PM (Principal Investigator). A Randomized, Double Blind, Placebo-Controlled, Dose-Finding, Multi-Center Study of Sandostatin LAR Depot (20mg, 40mg, 60mg) in Patients with Primary Insulin Hypersecretion (PIH) and at least Moderate Obesity. Funded by Novartis Corporation, $171,750; 2002.
O’Neil PM (Principal Investigator). Protocol #OT-10: Phase 2, Multi-Center, Randomized, Blinded, Placebo Controlled, Proof of Concept Study of Combination Therapy for Safety and Efficacy in Subjects with Uncomplicated Obesity. Funded by Orexigen Therapeutics, Inc., $202,401; 2003.
O’Neil PM (Principal Investigator). Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multi-Center Study to Evaluate the Efficacy, Tolerability, and Safety of Orlistat 60mg plus Diet in Patients with a BMI of > 25 and <28 kg/m2 Treated in a Primary Care Setting. Funded by Roche Consumer Health, $85,912; 2003.
O’Neil PM (Principal Investigator). A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety, Tolerability, and Efficacy of L-000753721 in Maintaining Weight Loss Induced by a Very Low Calorie Diet in Obese Patients. Funded by Merck, Inc., $187,449; 2003.
O’Neil PM (Principal Investigator). A Randomized, Triple-Blind, Placebo-Controlled, Multi-Center Study to Investigate the Safety and Tolerability of Progressive Dose-Escalation of Pramintide in Obese Subjects with Non-Insulin Treated Type 2 Diabetes and Obese Non-Diabetic Subjects. Funded by Amylin Pharmaceuticals, $60,875; 2003.
O’Neil PM (Principal Investigator). A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group Study to Assess the Efficacy and Safety of Toparimate OROS Controlled-Release in the Treatment of Obese, Type 2 Diabetic Subjects Managed with Diet of Metformin. Funded by Johnson and Johnson, $115,466; 2004.
O’Neil PM (Principal Investigator). A Randomized, Double Blind, Placebo-Controlled, Parallel Group, Fixed Dose, Multi-Center Study of Weight Reducing and Prevention of Weight Regain Effects and Safety of Rimonabant 20 mg Versus Placebo on Weight Loss and Frequency of Binge Episodes in Obese Patients with food cravings. Funded by Sanofi-Synthelabo, Inc, $72,382; 2004.
O’Neil PM (Principal Investigator). South Carolina Nutrition Research Consortium Project Management and Outreach. Funded by South Carolina Research Authority, $156,303; 2004.
O’Neil PM (Principal Investigator). South Carolina Nutrition Research Consortium Project Management and Outreach. Funded by South Carolina Research Authority, $63,572; 2004.
O’Neil PM (Principal Investigator). A Phase 2, Multi-Center, Randomized, Blinded, Placebo Controlled, Proof of Concept Study of Combination Therapy for Safety and Efficacy in Subjects with Uncomplicated Obesity. Funded by Orexigen Therapeutics, Inc, $123,788; 2004.
6
O’Neil PM (Principal Investigator). A Dose-Parallel, Randomized, Placebo-Controlled, Multicenter Study of the Safety and Efficacy of Multiple Regimens of the Combination of Zonisamide CR plus Bupropion SR in the Treatment of Subjects with Uncomplicated Obesity. Funded by Orexigen Therapeutics, $252,873; 2005.
O’Neil PM (Principal Investigator). A Dose-Parallel, Phase 2, Randomized, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy and Pharmacokinetics of Multiple Regimens of the Combination of Zonisamide CR plus Bupropion SR in the Treatment of Subjects with Uncomplicated Obesity. Funded by Orexigen Therapeutics, $303,125; 2006.
O’Neil PM (Principal Investigator). A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Three Doses of AVE1625 in Abdominally Obese Patients with Atherogenic Dyslipidemia. Funded by sanofi-aventis US, Inc., $99,300; 2006.
O’Neil PM (Principal Investigator). A 104-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Safety and Efficacy of Lorcaserin Hydrochloride in Obese Patients. Funded by Icon Clinical Research, Inc., $650,251; 2006.
O’Neil PM (Principal Investigator). A 2-Year (1-Year Weight Loss Followed by 1-Year Prevention of Weight Regain) to Assess the Safety, Tolerability, and Efficacy of L-000899055 in Obese Patients. Funded by Merck & Co., Inc, $523,666; 2005-2009
O’Neil PM (Principal Investigator). A 2-Year (1-Year Weight Loss Followed by 1-Year Prevention of Weight Regain) to Assess the Safety, Tolerability and Efficacy of L-00899055 in Obese Patients (Addendum). Funded by Merck, $125,622; 2005-2009
O’Neil PM (Principal Investigator). A Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multiple-Dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BMS-646256 (SLV319) in Obese and High Risk Overweight Subjects. Funded by Bristol Myers Squibb, $671,215; 2007-2009
O’Neil PM (Principal Investigator). A Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multiple-Dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BMS-646256 (SLV319) in Obese and High Risk Overweight Subjects (Addendum). Funded by Bristol Myers Squibb, $307,224; 2007-2009
O’Neil PM (Principal Investigator). A Multi-Center, Randomized, Double Blind, Placebo Controlled Study Comparing the Safety and Efficacy of Naltrexone Sustained Release (SR)/Bupropion Sustained Release (SR) and Placebo in Subjects with Obesity Participating in a Behavior Modification Program. Funded by Orexigen Therapeutics, Inc., $1,210,171; 2007-2009
Active support:
7
O’Neil PM (Principal Investigator). A 52-Week, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of Lorcaserin Hydrochloride in Overweight and Obese Patients with Type 2 Diabetes Mellitus Managed with Oral Hypoglycemic Agent(s) BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus. Funded by Arena Pharmaceuticals, Inc., $147,753; 2007-Present.
O’Neil PM (Principal Investigator). Troop Recruitment Improvement Program (TRIM)-Supplement. Funded by South Carolina Research Authority, $109,793; 2008-Present.
O’Neil PM (Principal Investigator). A 52-Week, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of Lorcaserin Hydydrochloride in Overweight and Obese Patients. Funded by Arena Pharmaceuticals, Inc., $328,121; 2008-Present.
O’Neil PM (Principal Investigator). A Pilot Study to Evaluate a Revised Method of Assessing Food in a Commercial Weight Management Program Format. Funded by Weight Watchers International, $500,000; 2008-Present.
As Co-Investigator:Past:Malcolm R (Principal Investigator). (O’Neil PM, Co-investigator). A Double-Blind
Controlled Study of Naltrexone in Obese Patients. Funded by E.I. DuPont, Inc, $48,300; 1983.
Ballenger JC (Principal Investigator). (O’Neil PM, Co-investigator). Fluoxetine vs. Placebo in Bulimia: Parallel/Blind (B1Y-MC-HCDN, IND 12274). Funded by Lilly Research Laboratories, $220,835; 1986–1987.
Ballenger JC (Principal Investigator). (O’Neil PM, Co-investigator). Fluoxetine vs. Placebo I: Intermittent Dosing in Obese Patients (Protocol B1Y-MC-HCEJ, IND 12274). Funded by Lilly Research Laboratories, $231,335; 1988–1989.
Ballenger JC (Principal Investigator). (O’Neil PM, Co-investigator). Lovan: Effect on Weight Maintenance after Very Low Calorie Diets (protocol B1Y-MC-HCGA, IND 12274). Funded by Lilly Research Laboratories, $178,478; 1991-1993. Supplemental funding of $48,352 approved 1993.
Donovan JL (Principal Investigator). (O’Neil PM, Co-investigator). Green Tea and Weight Loss in Obese Individuals. South Carolina Nutrition Research Consortium, $20,000; 2006-2009.
Active:
Malcolm R (Principal Investigator). (O’Neil PM, Co-Investigator). Study of Treatment of Binge Eating Patterns with CPP-109. Funded by Catalyst Pharmaceutical Partners, Inc, $356,368; 2008-Present.
Intramural Grants/amount of award:O’Neil PM (Principal Investigator). Obesity Typology and Treatment Outcome.
Funded by Medical University of South Carolina Institutional Grant for Biomedical Research, $7,644; July 1, 1982—June 30, 1983. Supplemental funding of $1,500 awarded.
8
Awards, Honors, Membership in Honorary Societies:1970 Psi Chi, National Honor Society in Psychology1973 Phi Kappa Phi, National Honor Society1973 Final oral examination for the M.S., passed with distinction1973 Clinical written preliminary examination for the Ph.D., passed with distinction2002 Best Research Mentor Award, Psychology Internship Program, MUSC
Major Teaching Responsibilities (Current):Undergraduate Medical Education
Course coordinator, Obesity Day (second-year medical students) 2007–2010Graduate Medical EducationGraduate Studies EducationContinuing Medical Education
CME lectures on obesity and its managementClinical psychology predoctoral internship:
Member, Psychology Education CommitteeResearch preceptorPresentation of seminars to psychology interns on eating disorders Supervision of psychology interns and other trainees in Weight
Management Center
Major Clinical Interests and Responsibilities:Obesity and weight loss
Lectures and Presentations: Invited lectures and presentationsO’Neil PM. Update on obesity. Paper presented at the 2005 Preferred Blue Physician
Conference, Isle of Palms, SC, June 2005.
O’Neil PM. Who is the extremely obese patient? Paper presented at the EMBRACE™ scientific roundtable, Atlanta, GA, December 2006.
O’Neil PM. Weighing the evidence on current and future obesity treatments. Paper presented at the 2007 Update in Psychiatry, Charleston, SC, June 2007.
9
O’Neil PM. Weight loss supplements. Paper presented at the South Carolina Chapter Scientific meeting, Charleston, SC, October 2007.
O’Neil PM. An update on weight loss interventions. Paper presented at The New Drug Update, Charleston, SC, May 2008.
O’Neil PM. An update on weight loss interventions. Paper presented at the Great Lakes Metabolic Syndrome Symposium, Detriot, MI, May 2008.
O’Neil PM. An update on weight loss interventions. Paper presented at the South Atlantic Metabolic Syndrome Symposium, Atlanta, GA, June 2008.
O’Neil PM. Update on the management of obesity. Paper presented at the 2008 Physician Conference for Preferred Blue, Isle of Palms, SC, June 2008.
O’Neil PM. Behavior modification in the treatment of obesity. Paper presented at the 9th Annual Conference on Obesity: New Frontiers in Metabolic Wellness, Orlando, FL, September 2008.
Submitted presentations Lundgren JD, O’Neil PM, Malcolm R, Binks M. Metabolic syndrome and weight loss.
Poster presented at the annual meeting of the North American Association for the Study of Obesity, Vancouver, British Columbia, October 2005.
Ames G, O’Neil PM, Roitzsch J, White M, Byrne T. Weight goals of gastric bypass applicants. Poster presented at the annual meeting of the North American Association for the Study of Obesity, Vancouver, British Columbia, October 2005.
O’Neil PM. Obesity in children and adolescents. Poster presented at Frontiers in Pediatrics CME conference, Charleston, SC, December 2005.
O’Neil PM. Obesity treatment and prevention. Poster presented at the Fourth Annual Diabetes/CVH Winter Symposium, Myrtle Beach, SC, March 2006.
Greenway F, Anderson J, Atkinson R, Fujioka K, Gadde KM, Gupta A, O’Neil PM, Schumacher D, Smith D, Whitehouse MF, Cruickshank S, Guttadauria M, Cowley MA. Bupropion and zonisamide for the treatment of obesity. Paper presented at the annual meeting of the North American Association for the Study of Obesity, Boston, MA, October 2006.
Erondu J, Wadden T, Gantz I, Musser B, Nguyen AM, Bays H, Bray G, O’Neil PM, Basdevant A, Kaufman K, Heysmfield S, Amatruda J. Effect of NPY5R antagonist MK-0557 on weight regain after VLCD-induced weight loss. Paper presented at the annual meeting of the North American Association for the Study of Obesity, Boston, MA, October 2006.
White M, Martin C, O’Neil PM, Tollefson G, Greenway F. The relationship between specific food cravings and food consumption in a laboratory taste test. Poster presented at the annual meeting of the North American Association for the Study of Obesity, Boston, MA, October 2006.
Lundgren JD, O’Neil PM, Malcolm R, Binks M. Psychosocial characteristics of weight loss patients with and without metabolic syndrome. Poster presented at the annual
10
meeting of the North American Association for the Study of Obesity, Boston, MA, October 2006.
Bodenlos JS, Kose S, Borckardt J, Nahas Z, Shaw D, O’Neil PM, George M. The effects of vagus nerve stimulation on food craving in depressed adults. Poster presented at the annual meeting of the North American Association for the Study of Obesity, Boston, MA, October 2006.
Cowley MA, Tollefson G, Gutadauria M, Gadde KM, Bassion S, Whitejouse MJ, Cruickshank S, Fujioka K, O’Neil PM, Anderson J, Gupta A, Smith D, Schumacher D, Atkinson R, Greenway F. Opioid antagonists synergize with bupropion to cause weight loss. Poster presented at the annual meeting of the North American Association for the Study of Obesity, Boston, MA, October 2006.
Greenway F, Fujioka K, Anderson J, Raj YP, Gupta A, O’Neil PM, Smith D, Schumacher D, Guttadauria M, Dunayevich E, Cruickshank S, Cowley M, Tollefson G. A double-blind, placebo-, bupropion- and naltrexone monotherapy controlled study of the efficacy and safety of 3 doses of combined naltrexone-bupropion SR therapy in obesity: 24 and 48 week data. Paper presented at the annual meeting of The Obesity Society, New Orleans, LA, October 2007.
Coletta M, Byrne K, Budak A, Brown J, O’Neil PM. A comparison of the HADS-D and BDI-II as screening tools for depression in patients requesting bariatric surgery. Poster presented at the annual meeting of The Obesity Society, New Orleans, LA, October 2007.
O’Neil PM, Foster G, Billes SJ, Dunayevich E, Kim DD. Early weight loss with naltrexone SR/bupropion SR combination therapy for obesity predicts log-term weight loss. Poster presented at the annual meeting of The Obesity Society, Washington, DC, November 2009.
Brown JD, Hendrix E, O’Neil PM. Relation of payment method to completion of a fee-for-service comprehensive weight loss program. Poster presented at the annual meeting of The Obesity Society, Washington, DC, November 2009.
Boeka AG, Lokken KL, Miller-Kovach K, Cronan GE, O’Neil PM. Relations of hedonic hunger and binge eating among treatment-seeking overweight and obese adults. Poster presented at the annual meeting of The Obesity Society, Washington, DC, November 2009.
Ambwani S, Boeka AG, Brown JD, Byrne TK, Budak AR, Sarwer DB, Fabricatore AN, Eisenberg MH, O’Neil PM. Correlates of socially desirable responding among bariatric surgery candidates. Poster presented at the annual meeting of The Obesity Society, Washington, DC, November 2009.
O’Neil PM, Boeka A, Cronan G, Miller-Kovach K. Changes in weight-related behaviors and hedonic hunger with participation in a 12-week weight loss trial using a commercial format. Presented at the annual meeting of The Society of Behavioral Medicine, Seattle, WA, April 2010.
Extramural Professional Activities: Professional service activities:1997–1998 Ad Hoc Member, NIH Behavioral Medicine Study Section
Curriculum Committee, South Carolina School of Alcohol and Drug Studies, 1979, 1981Co-organizer, Annual Advanced Workshops for Health-Care Professionals, South
Carolina School of Alcohol and Drug Studies, 1978–1981Advisory Committee, Charleston County Substance Abuse Commission, 1981–1984Instructor, Community Education Courses (Weight Control, Alcoholism), Medical
University of South Carolina, Department of Psychiatry and Behavioral Sciences, 1981
Author, “Weighing the Choices” weekly column on weight control, Charleston Sunday Post and Courier, 1987–1996
Member, South Carolina State Board of Examiners in Psychology, 1991–1996Secretary, 1992–1993Vice-Chair, 1993–1995Chair, 1995–1996
Member, Town of Sullivan’s Island Planning and Zoning Commission, 1993–2001Chair, 1999–2001
Member, Town of Sullivan’s Island Town Council, 2001–PresentMayor Pro Tem, 2005–2009
Publications: Peer Reviewed Journal Articles:
Peed S, Turner S, Forehand R, Gardner H, O'Neil P. The effects of the amount of reinforcement on imitation. Psychological Reports, 1974, 30, 34.
O'Neil PM, Calhoun KS. Sensory deficits and behavioral deterioration in senescence. Journal of Abnormal Psychology, 1975, 84, 579–582.
O'Neil PM, Roitzsch JC. Assertiveness training for alcohol abusers: Rationale and application. British Journal of Alcohol and Alcoholism, 1977, 12, 107–113.
Beiman I, O'Neil PM, Wachtel D, Fruge E, Johnson S, Feuerstein M. Validation of a self-report/behavioral subject selection procedure for analogue fear research. Behavior Therapy, 1978, 9, 169–177.
O'Neil PM, Currey HS, Hirsch AA, Riddle FE, Taylor CI, Malcolm RJ, Sexauer JD. Effects of sex of subject and spouse involvement on weight loss in a behavioral treatment program: A retrospective investigation. Addictive Behaviors, 1979, 4, 167–177. (Also selected for abstraction in Obesity & Bariatric Medicine, 1979, 8, 171.)
O'Neil PM, White JL, King CR Jr, Carek DJ. Controlling childhood rumination through differential reinforcement of other behavior. Behavior Modification, 1979, 3, 355–372.
Malcolm R, Robson JRK, Vanderveen TW, O'Neil PM. Psychosocial aspects of total parenteral nutrition. Psychosomatics, 1980, 21, 115-125.
O'Neil PM, Sutker PB, Kilpatrick DG, Keeler MH. Programmed self-instruction on alcoholism for medical students: A controlled evaluation. Journal of Psychiatric Education, 1980, 4, 201-212.
Sutker PB, O'Neil PM. Evaluation of a drug abuse educational course for law enforcement and treatment specialists. International Journal of the Addictions, 1980, 15, 125-135.
13
Malcolm R, O'Neil PM, Hirsch AA, Currey HS, Moskowitz G. Taste hedonics and thresholds in obesity. International Journal of Obesity, 1980, 4, 203-212.
Paine PM, O'Neil PM, Malcolm R, Sexauer JD, Currey HS. Experienced control and participation in treatment of obesity. Psychological Reports, 1980, 47, 1127-1134.
O'Neil PM, Currey HS, Hirsch AA, Malcolm RJ, Sexauer JD, Riddle FE, Taylor CI. Development and validation of the Eating Behavior Inventory. Journal of Behavioral Assessment, 1979, 1, 123-132. (Also selected for abstraction in Obesity & Bariatric Medicine, 1981, 10, 111.)
O'Neil PM, Paine PM, Riddle FE, Currey HS, Malcolm R, Sexauer JD. Restraint and age at onset of obesity. Addictive Behaviors, 1981, 6, 135-138, (also selected for abstraction in International Journal of Obesity, 1981, 7, 179.)
O'Neil PM, Currey HS, Malcolm R, Francis WB, Riddle FE, Sexauer JD. Calorie counting by obese and non-obese subjects. Obesity and Bariatric Medicine, 1982, 11, 18-20.
O'Neil PM, Roitzsch JC, Giacinto JP, Miller WC. Disulfiram acceptors and refusers: Do they differ? Addictive Behaviors, 1982, 7, 207-209.
O'Neil PM, Roitzsch JC, Giacinto JP, Miller WC. Temporal stability of the Experienced Control Scale within an alcoholic male population. Journal of Clinical Psychology, 1982, 38, 886-890.
O'Neil PM, Giacinto JG, Waid LR, Roitzsch JC, Miller WC, Kilpatrick DG. Behavioral, psychological, and historical correlates of MacAndrew scale scores among male alcoholics. Journal of Behavioral Assessment, 1983, 5, 261-273.
Malcolm R, O'Neil PM, Sexauer JD, Riddle FE, Currey HS, Counts C. A controlled trial of naltrexone in obese humans. International Journal of Obesity, 1985, 9, 347-353.
Malcolm R, O'Neil P, Von J, Dickerson P. Naltrexone and dysphoria: A double-blind placebo controlled trial. Biological Psychiatry, 1987, 22, 710-716.
Malcolm R, Von J, O'Neil P, Currey H, Sexauer J, Riddle L. Update on the management of obesity. Southern Medical Journal, 1988, 81, 632-639.
Lydiard RB, Brady KT, O'Neil PM, Schlesier-Carter B, Hamilton S, Rogers Q, Ballenger JC. Precursor amino acid concentrations in normal weight bulimics and normal controls. Prog Neuro-Psychopharmacol and Biol Psychiatry, 1988, 12, 893-899.
Schlesier-Carter B, Hamilton SA, O'Neil PM, Lydiard RB, Malcolm R. Depression and bulimia: The link between depression and bulimic cognitions. Journal of Abnormal Psychology, 1989, 98, 322-325.
Kay WH, Ballenger JC, Lydiard RB, Stuart GW, Laraia MT, O'Neil PM, Fossey MD, Stevens V, Lesser S, Hsu G. CSF monoamine levels in normal-weight bulimia: Evidence for abnormal noradrenergic activity. American Journal of Psychiatry, 1990, 147, 225-229.
14
O'Neil PM. Disturbing threat to academic obfuscation. (Comment). American Psychologist, 1991, 46, 1090.
O'Neil PM, Jarrell MP. Psychological aspects of obesity and very low calorie diets. American Journal of Clinical Nutrition, 1992, 56, 185S-189S.
Lydiard RB, Morton WA, Emmanuel NP, Zealberg JJ, Laraia MT, Stuart GS, O'Neil PM, Ballenger JC. Preliminary report: Placebo-controlled, double-blind study of the clinical and metabolic effects of desipramine in panic disorder. Psychopharmacology Bulletin, 1993, 29, 183-188.
Brewerton TD, Lydiard RB, Herzog DB, Brotman AW, O'Neil PM, Ballenger JC. Comorbidity of axis I psychiatric disorders in bulimia nervosa. Journal of Clinical Psychiatry, 1995, 56(2), 77-80.
Rhodes SK, Shimoda KC, Waid LR, O'Neil PM, Oexmann MJ, Collop NA, Willi SM. Neurocognitive deficits in morbidly obese children with obstructive sleep apnea. Journal of Pediatrics, 1995, 127, 741-744.
Dansky BS, Brewerton TD, Kilpatrick DG & O’Neil PM. The National Women’s Study: Relationship of victimization and posttraumatic stress disorder to bulimia nervosa. International Journal of Eating Disorders, 1997, 3: 213-28.
Rhodes SK, O’Neil PM. Effects of body fat distribution on body size estimation accuracy among obese women. International Journal of Obesity, 1997, 21, 250-253.
Varnado P, Williamson D, Bentz B, Ryan D, Rhodes SK, O’Neil PM, Sebastian S, Barker S. Prevalence of binge eating disorder in obese adults seeking weight loss treatment. Eating and Weight Disorders, 1998, 2(3), 117-124.
Stevens J, Plankey MD, Williamson DF, Thun MJ, Rust PF, Palesch Y, O’Neil PM. The body mass index-mortality relationship in white and African American women. Obesity Research, 1998, 6(4), 268-277.
Anderson JW, Pi-Sunyer FX, Danforth E, Dujovne CA, Greenway F, Hill JO, Lucas CP, O’Neil PM, Smith DK. Clinical trial design for obesity agents: A workshop report. Obesity Research, 1998, 6(4), 311.
Pellegrin KL, O’Neil PM, Stellefson EJ, Fossey MD, Ballenger JC, Cochrane CE, Currey HS. Average daily nutrient intake and mood among obese women. Nutrition Research, 1998, 18, 1103-1112.
Smith CF, O’Neil PM, Rhodes SK. Cognitive appraisals of dietary transgressions by obese women: Associations with self-reported eating behavior, depression, and actual weight loss. International Journal of Obesity and Related Metabolic Disorders, 1999, 23, 231-237.
Hill JO, Hauptman J, Anderson JW, O’Neil PM, Smith DK, Zavoral JH, Aronne LJ. Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: A 1-year study. American Journal of Clinical Nutrition, 1999, 69, 1108-1116.
O’Neil PM, Smith CF, Foster GD, Anderson DA. The perceived relative worth of reaching and maintaining goal weight. International Journal of Obesity and Related Metabolic Disorders, 2000, 24, 1069-1076.
15
Yanovski JA, Yanovski SZ, Sovik KN, Nguyen TT, O’Neil PM, Sebring NG. A prospective study of holiday weight gain. New England Journal of Medicine, 2000, 342, 861-867.
Oexmann MJ, Thomas JC, Taylor KB, Garvey WT, O’Neil PM, Lackland DT, Egan BM. Short-term impact of a church-based approach to lifestyle change on cardiovascular risk in African-Americans. Ethnicity and Disease, 2000, 10, 17-23.
Brewerton TD, O’Neil PM, Kilpatrick DG, Dansky BS. Which comes first in the pathogenisis of bulimia nervosa: Dieting or bingeing? International Journal of Eating Disorders, 2000, 28, 259-264.
O’Neil PM. Assessing dietary intake in the management of obesity. Obesity Research, 2001, 9, 361S–366S.
Binks M, O’Neil PM. Referral sources to a weight management program: Relationship to outcome. Journal of General Internal Medicine, 2002, 17, 596–603.
Martin CK, O’Neil PM, Binks M. An attempt to identify predictors of treatment outcome in two comprehensive weight loss programs. Eating Behaviors, 2002, 3, 239–248.
Anderson JW, Greenway F, Fujioka K, Gadde KM, McKinney J, O’Neil PM. Bupropion SR enhances weight loss: A 48-week double-blind, placebo-controlled trial. Obesity Research, 2002, 10, 633–641.
Pawlow L, O’Neil PM, Malcolm R. Night eating syndrome: Effects of brief relaxation training on stress, mood, hunger, and eating patterns. International Journal of Obesity, 2003, 27, 970–978.
White MA, O’Neil PM, Kolotkin RL, Byrne TK. Gender, race, and obesity-related quality of life at extreme levels of obesity. Obesity Research, 2004, 12(6), 949-955.
O’Neil PM, Rieder S. Utility and validity of the Eating Behavior Inventory in clinical obesity research: A review of the literature. Obesity Reviews, 2005, 6, 209–216.
O’Neil PM, Brown JD. Weighing the evidence: Benefits of regular weight monitoring for weight control. Journal of Nutrition Education and Behavior, 2005, 37, 319–322.
Pawlow LA, O’Neil PM, White MA, Byrne TK. Findings and outcomes of psychological evaluations of gastric bypass applicants. Surgery for Obesity and Related Diseases, 2005, 1, 523–529.
Lundgren JD, O’Neil PM, Martin CK, Binks M. Smoking status and weight loss in three weight loss programs. Eating Behaviors, 2006, 7, 61–68.
Martin CK, O’Neil PM, Pawlow L. Changes in food cravings during low-calorie and very-low-calorie diets. Obesity, 2006, 14, 115–121.
Bodenlos JS, Kose S, Borckardt JJ, Nahas Z, Shaw D, O’Neil PM, George MS. Vagus nerve stimulation acutely alters food craving in adults with depression. Appetite, 2007, 48, 145-153.
Erondu N, Wadden T, Gantz I, Musser B, Nguyen Am, Bays H, Bray G, O’Neil PM, Basdevant A, Kaufman KD, Heymsfield SB, Amatruda JM. Effect of NPY5R
16
antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight loss. Obesity, 2007, 15(4), 895-905.
Borckhardt JJ, Nash MR, Murphy MD, Moore M, Shaw D, O’Neil P. Clinical practice as natural laboratory for psychotherapy research: a guide to case-based time-series analysis. American Psychologist, 2008, 63(2), 77-95.
Greenway FL, Whitehouse MJ, Guttadauria M, Anderson JW, Atkinson RL, Fujioka K, Gadde KM, Gupta AK, O’Neil P, Schumacher D, Smith D, Dunayevich E, Tollefson GD, Weber E & Cowley MA. Rational design of a combination medication for the treatment of obesity. Obesity, 2008, 17(1), 130-139.
Martin CK, O’Neil PM, Tollefson G, Greenway FL & White MA. The association between food cravings and consumption of specific foods in a laboratory taste test. Appetite, 2008, 51(2), 324-326.
Lundgren JD, Malcolm R, Binks M & O’Neil PM. Remission of metabolic syndrome following a 15-week low-calorie lifestyle change program for weight loss. International Journal of Obesity, 2009, 33, 144-150.
Published Abstracts:Malcolm R, Paine PM, Neumann K, O’Neil PM. Cognitive and perceptual correlates of
age at onset of obesity. Alimentazione Nutrizione Metabolismo, 1980, 1, 311 (Abstract).
O’Neil PM, Currey HS, Sexauer JD, Riddle FE, Molony-Sinnott V. Persistence at three year follow-up of male-female differences in weight loss. Alimentazione Nutrizione Metabolismo, 1980, 1, 333 (Abstract).
Riddle FE, Currey HS, Paine PM, O’Neil PM. Effects of a relapse prevention component in a behavioral weight management program. Alimentazione Nutrizione Metabolismo, 1980, 1, 347 (Abstract).
Giacinto JP, O’Neil PM, Waid LR, Roitzsch JC. A comparison of early-onset versus late-onset elderly alcoholic males. Alcoholism: Clinical and Experimental Research, 1981, 5, 150 (Abstract).
O’Neil PM, Waid LR, Miller WC, Giacinto JP. Psychological and behavioral correlates of MacAndrew Scale scores among male alcoholics. Alcoholism: Clinical and Experimental Research, 1981, 5, 163 (Abstract).
Waid LR, Kilpatrick DG, Malatesta V, O’Neil PM. Substance abuse patterns and psychosocial characteristics of young, middle-aged, and elderly alcoholic males. Alcoholism: Clinical and Experimental Research, 1981, 5, 171 (Abstract).
O'Neil PM, Malcolm R, Shipp D, Von J, Sexauer J, Riddle FE. Cognitive and compliance variables related to outcome in a supplemented fasting program. International Journal of Obesity, 1987, 11, 449A (Abstract).
O'Neil PM, Bene CR, Jarrell MP, Fossey MD, Ballenger JC. RMR and eating-related psychological measures. International Journal of Obesity, 1990, 14 (Supplement 2), 38 (Abstract).
17
Fossey MD, Jarrell MP, Bene CR, O'Neil PM, Ballenger JC. Physical and psychological predictors of early weight loss. International Journal of Obesity, 1990, 14 (Supplement 2), 146 (Abstract).
Bene CR, Klesges RC, Burks M, O'Neil PM. The impact of weight cycling on energy balance and response to treatment. International Journal of Obesity, 1991, 15 (Supplement 3), 45 (Abstract).
O'Neil PM, Pellegrin KL, Jarrell MP, Samo JA, Fossey MD, Ballenger JC, Cochrane CE, Currey HS, Jones CR, Bene CR. Does anxiety affect resting metabolic rate? International Journal of Obesity, 1991, 15 (Supplement 3), 47 (Abstract).
Fossey MD, Jarrell MD, Bene CR, O’Neil PM, Ballenger JC. Predictors of early placebo response in women treated for obesity. Psychosomatic Medicine, 1991, 53(2), 225 (Abstract).
O'Neil PM, Dansky BS, Kilpatrick DG, Brewerton TD. Dieting by U.S. women: Prevalence, practices, and results by weight category. Annals of Behavioral Medicine, 1993, 15 (Supplement), S39 (Abstract).
Dansky BS, Kilpatrick DG, Brewerton TD, O'Neil PM. The relationship between bulimia and victimization in a national representative sample of women. Annals of Behavioral Medicine, 1993, 15 (Supplement), S67 (Abstract).
Dansky BS, O'Neil PM, Brewerton TD, Kilpatrick DG. The nature of the relationship between obesity and victimization in a national sample of U.S. women. Annals of Behavioral Medicine, 1993, 15 (Supplement), S67 (Abstract).
O'Neil PM, Dansky BS, Kilpatrick DG, Brewerton TD. Methods and results of dieting by U.S. women: Preliminary findings from the national women's study. Obesity Research, 1993, 1 (Supplement 1), 45S (Abstract).
O'Neil PM, Fossey MD, Ballenger JC, Currey HS, Cochrane CE, Jones CR, Jarrell MP. Fluoxetine and resting metabolic rate during weight loss treatment. Obesity Research, 1993, 1 (Supplement 1), 50S (Abstract).
O'Neil PM, Dansky BS, Kilpatrick DG, Brewerton TD. Effects of patient's degree overweight and race on physician behaviors to encourage weight loss. Obesity Research, 1993, 1 (Supplement 2), 83S (Abstract).
Rhodes SK, O'Neil PM, Cook VL, Webster DA, Jarrell MP. Effects of body fat distribution on body image and other psychological variables. Obesity Research, 1993, 1 (Supplement 2), 112S (Abstract).
18
Brewerton TD, Dansky BS, O’Neil PM, Kilpatrick DG. The prevalence of binge eating disorder in U.S. women. CME Syllabus and Proceedings Book: 146th Annual Meeting of the American Psychiatric Association. San Francisco, CA. May 1993 (Abstract #P86, 104).
Dansky BS, Brewerton TD, O’Neil PM, Kilpatrick DG. Rape, PTSD, and bulimia in a sample of United States women. New Research Program and Abstracts: 146th Annual Meeting of the American Psychiatric Association. San Francisco, CA. May 1993 (Abstract #NR224, 115).
Dansky BS, Brewerton TD, Resnick HS, O’Neil PM, Kilpatrick DG. Bulimia nervosa and alcohol abuse in a national sample of women. Proceedings of the Annual Meeting of the American Psychological Association. Toronto, Canada. August 1993 (Abstract).
Dansky BS, Brewerton TD, Resnick HS, O’Neil PM, Kilpatrick DG. Individual and family history characteristics for women with bulimia nervosa and binge eating disorder: Findings from the National Women’s Study. Proceedings of the Annual Meeting of the Association for the Advancement of Behavior Therapy. November 1993, 137 (Abstract).
Cochrane CE, Brewerton TD, O’Neil PM, Currey H, Fossey M, Ballenger JC. Alexithymia in obese patients with and without binge eating disorder. Abstracts of the Sixth Annual International Conference on Eating Disorders, 1994 (Abstract #313).
O'Neil PM, Dansky BS, Kilpatrick DG, Brewerton TD. Prevalence and correlates of physician behaviors to encourage weight loss. Annals of Behavioral Medicine, 1994, 16, (Supplement), S72 (Abstract).
Rhodes SK, Shimoda KC, Waid LR, O’Neil PM, Oexmann MJ, Willi SM, Collop NA. Cognitive deficits in morbidly obese adolescents with sleep apnea. International Journal of Obesity, 1994, 18(2), 13 (Abstract).
Plankey MW, Stevens J, Palesch YY, Rust PF, O’Neil PM, Williamson DF. The impact of education and smoking on the BMI-mortality relationship in white and African American women. Obesity Research, 1995, 3 (Supplement 3), 386s (Abstract).
Rhodes SK, Shepherd KI, O’Neil PM, Resnick HS. Fat distribution and sexual trauma in Obese women. Obesity Research, 1995, 3, (Supplement 3), 399S (Abstract).
Hackett J, Staten M, Manyak C, Foreyt JP, DiGirolamo M, Hill JO, Lucas CP, O’Neil PM. Predictors of leptin among subjects with relative leptin deficit or excess compared with values predicted from a model. Obesity Research, 1996, 4, (Supplement 1), 35S (Abstract).
Amgen 950247 Study Group. Characterization of serum leptin concentrations in the general adult population. Obesity Research, 1996, 4, (Supplement 1), 36S (Abstract).
Varner LM, O’Neil PM. Clinical improvement in hypertension following very-low-calorie-diet treatment. Obesity Research, 1996, 4, (Supplement 1), 55S (Abstract).
O’Neil PM, Smith CF, Foster GD, Anderson DA. The perceived relative worth of weight loss. Obesity Research, 1997, 5 (Supplement 1), 72S (Abstract).
Smith CF, O’Neil PM, Rhodes SK. Relations of cognitive styles to eating behavior, depression, and weight loss. Obesity Research, 1997, 5 (Supplement 1), 80S (Abstract).
O’Neil PM, Smith CF, Foster GD, Anderson DA, Wadden TA. Weight loss targets among clinical and community samples. International Journal of Obesity and Related Metabolic Disorders, 1998, 22 (Supplement 3), S285 (Abstract).
Womble LG, O’Neil PM, Thompson OM. An examination of the associations among media and weight variables in a community sample. Obesity Research, 1999, 7 (Supplement 1), 42S (Abstract).
Yanovski JA, Yanovski SZ, Sovik KN, Nguyen TT, O’Neil PM, Sebring NG. A prospective study of holiday weight gain Obesity Research, 1999, 7, (Supplement 1), 55S (Abstract).
Brewerton TD, O’Neil PM, Dansky BS, Kilpatrick DG. Links between morbid obesity, victimization, PTSD, major depression and bulimia in a national sample of women. Obesity Research, 1999, 7 (Supplement 1), 56S (Abstract).
Festa J, Rogers RL, Neal L, O’Neil PM. Menopausal status, hormone replacement therapy, and weight loss on a very-low-calorie-diet: A retrospective analysis. Obesity Research, 1999, 7 (Supplement 1), 102S (Abstract).
Binks M, O’Neil PM. Type of referral to a weight management program: Relationship to outcome. Obesity Research, 2000, 8 (Supplement 1), 49S (Abstract).
Foster KY, Lund AJ, O’Neil PM, Pinkston M. Within-meal order and subsequent food consumption. Obesity Research, 2000, 8 (Supplement 1), 62S (Abstract).
Anderson JW, Fujjoka K, Gadde K, Greenway F, O’Neil PM. Clinical trial using bupropion SR with a moderate-intensity lifestyle intervention. Obesity Research, 2000, 8 (Supplement 1), 88S (Abstract).
Binks M, O’Neil PM, Martin CK. Use of a single item to assess binge eating. Obesity Research, 2001, 9 (Supplement 3), 129S (Abstract).
Martin CK, O’Neil PM. An attempt to identify predictors of treatment outcome in two comprehensive weight loss programs. Obesity Research, 2001, 9 (Supplement 3), 193S (Abstract).
Rieder S, O’Neil P. Factor structure of the Eating Behavior Inventory. Obesity Research, 2004, 12 (Supplement), A (Abstract).
Binks M, O’Neil P, Martin C, Raus A, Malcolm R. Outcomes of a brief individually delivered moderate carbohydrate weight loss program based on proven treatment
20
elements and patient preferences. Obesity Research, 2004, 12 (Supplement), A62 (Abstract).
Lundgren J, O’Neil P, Martin C, Binks M. Smoking and weight loss in three weight loss programs. Obesity Research, 2004, 12, (Supplement), A72 (Abstract).
Pawlow L, O’Neil P, White M, Byrne T. Rates of psychological contraindication and referral for gastric bypass applicants. Obesity Research, 2004, 12 (Supplement) A86 (Abstract).
Pawlow L, O’Neil P, White M, Byrne T. Psychotropic medication use by gastric bypass surgery applicants. Obesity Research, 2004, 12 (Supplement) A87 (Abstract).
Lundgren J, O’Neil PM, Malcolm R, Binks M. Metabolic syndrome and weight loss. Obesity, 2005, 13 (Supp) A83 (Abstract).
Ames G, O’Neil P, Roitzsch J, White M, Byrne T. Weight goals of gastric bypass applicants. Obesity, 2005, 13 (Supp) A188 (Abstract).
Greenway F, Anderson J, Atkinson R, Fujioka K, Gadde KM, Gupta A, O’Neil PM, Schumacher D, Smith D, Whitehouse MJ, Cruickshank S, Guttadauria M, Cowley MA. Bupropion and zonisamide for the treatment of obesity. Obesity, 2006, 14 (Supp) A17 (Abstract).
Erondu N, Wadden T, Gantz I, Musser B, Nguyen AM, Bays H, Bray G, O’Neil PM, Basdevant A, Kaufman K, Heymsfield S, Amatruda J. Effect of NPY5R antagonist MK-0557 on weight regain after LSCD-induced weight loss. Obesity, 2006, 14 (Supp) A18 (Abstract).
White M, Martin C, O’Neil PM, Tollefson G, Greenway F. The relationship between specific food cravings and food consumption in a laboratory taste test. Obesity, 2006, 14 (Supp) A68 (Abstract).
Lundgren J, O’Neil PM, Malcolm R, Binks M. Psychosocial characteristics of weight loss patients with and without metabolic syndrome. Obesity, 2006, 14 (Supp) A81 (Abstract).
Bodenlos JS, Kose S, Borckardt J, Nahas Z, Shaw D, O’Neil PM, George M. The effects of vagus nerve stimulation on food craving in depressed adults. Obesity, 2006, 14 (Supp) A93 (Abstract).
Cowley MA, Tollefson G, Guttadauria M, Gadde KM, Bassion S, Whitehouse MJ, Cruickshank S, Fujioka K, O’Neil PM, Anderson J, Gupta A, Smith D, Schumacher D, Atkinson D, Greenway F. Opioid antagonists synergize with bupropion to cause weight loss. Obesity, 2006, 14 (Supp) A129 (Abstract).
Greenway F, Fujioka K, Anderson J, Raj YP, Gupta A, O’Neil P, Smith D, Schumacher D, Guttadauria M, Dunayevich E, Cruickshank S, Cowley M, Tollefson G. A double-blind, placebo-, bupropion- and naltrexone monotherapy controlled study of the efficacy and safety of 3 doses of combined naltrexone-bupropion SR therapy in obesity: 24 and 48 week data. Obesity, 2007, 15 (Supp) A45 (Abstract).
Coletta M, Byrne K, Budak A, Brown J, O’Neil PM. A comparison of the HADS-D and BDI-II as screening tools for depression in patients requesting bariatric surgery. Obesity, 2007, 15 (Supp) A142 (Abstract).
21
O’Neil PM, Foster G, Billes SJ, Dunayevich E, Kim DD. Early weight loss with naltrexone SR/bupropion SR combination therapy for obesity predicts log-term weight loss. Obesity, 2009, 17 (Supp) S109 (Abstract).
Brown JD, Hendrix E, O’Neil PM. Relation of payment method to completion of a fee-for-service comprehensive weight loss program. Obesity, 2009, 17 (Supp) S121 (Abstract).
Boeka AG, Lokken KL, Miller-Kovach K, Cronan GE, O’Neil PM. Relations of hedonic hunger and binge eating among treatment-seeking overweight and obese adults. Obesity, 2009, 17 (Supp) S316 (Abstract).
Ambwani S, Boeka AG, Brown JD, Byrne TK, Budak AR, Sarwer DB, Fabricatore AN, Eisenberg MH, O’Neil PM. Correlates of socially desirable responding among bariatric surgery candidates. Obesity, 2009, 17 (Supp) S286 (Abstract).
O’Neil PM, Boeka A, Cronan G, Miller-Kovach K. Changes in weight-related behaviors and hedonic hunger with participation in a 12-week weight loss trial using a commercial format. Annals of Behavioral Medicine, 2010, 39 (Supp) S211 (Abstract).
Non- Peer Reviewed Journal Articles: O’Neil PM. Review of Nutrition and Behavior, RB Kamarek, Ed., Alan R Liss, Inc. In
Ecology of Food and Nutrition, 1984, 14, 81-82.
O’Neil PM. Questions we have heard too often — and ones we should have heard. Weight Control Digest — Professional Edition, 1991, 1, 61-62.
O’Neil PM. Great (and not so great) expectations. Weight Control Digest — Professional Edition, 1992, 2, 212-213.
O’Neil PM. Summary and commentary concerning “Effects of weight cycling on metabolic control in male outpatients with non-insulin-dependent diabetes mellitus,” Schott DE, Cohen E, Singh SP, Health Psychology, 1990, 9, 599-605. In Diabetes Spectrum, 1992, 5, 226-227.
O’Neil PM, Pellegrin KP. Review of Improving the Long-Term Management of Obesity, MG Perri, AM Nezu, BJ Viegener (Eds.), John Wiley & Sons, 1992. In The Behavior Therapist, 1993, 16.
O’Neil PM, Smith CF. Choosing the right weight control program. The Weight Control Digest, 1997, 7, 665.
O’Neil PM. Excess weight is now a federal case, and it’s about time (Editorial). The Weight Control Digest, 1998, 8, 747.
O’Neil PM, Rogers R. Healthcare providers’ unhealthy attitudes toward obese people. The Weight Control Digest, 1998, 8.
O’Neil PM, Womble LG. Weight management and your spouse/partner: For better or worse. The Weight Control Digest 1999; 9: 859, 862–864.
O’Neil PM. Review of Handbook of Obesity Treatment, TA Wadden, AJ Stunkard (Eds.), Guilford Press, 2002. In JAMA, 2003, 289(14), 1860-1861.
22
O’Neil PM, Pawlow LA. Review of The Psychology of Eating: From Healthy to Disordered Behavior, J. Ogden, Oxford, England: Blackwell Publishing, 2002. In Gastroenterology, 2004, 126, 366.
Scholarly Books and Monographs : O’Neil PM. Effects of predictability of shock onset in faradic aversion therapy:
Illustration in the treatment of onychophagia. Doctoral dissertation, University of Georgia, 1975.
Chapters in Scholarly Books and Monographs:Miller P, O’Neil PM, Malcolm R, Currey HS. Eating disorders. In HE Adams, PB Sutker
(Eds.), The Comprehensive Handbook of Psychopathology. New York: Plenum Publishing Corp., 1984.
O'Neil PM, Jarrell MP. Psychological aspects of obesity and dieting. In TA Wadden, TB Van Itallie (Eds.), Treatment of the Seriously Obese Patient. New York: Guilford Press, 1992.
Brownell KD, O’Neil PM. Obesity. In DH Barlow (Ed.), Clinical Handbook of Psychological Disorders (2nd edition). New York: Guilford Press, 1993.
O’Neil PM, Rhodes SK. Module 2: Assessment, screening and goal-setting. In DL Hager, BK Wolfe (Eds.), The Lifestyle Counselor's Guide for Weight Control. Dallas: American Health Publishing Company, 1996.
Brewerton TD, Dansky BS, Kilpatrick DG, O’Neil PM. Bulimia nervosa, PTSD and “forgetting:” Results from the National Women’s Study. In LM Williams, VL Banyard (Eds.), Trauma and Memory. Durham: Sage Press, 1997.
Stellefson EJ, O’Neil PM. Binge eating. In S St. Jeor (Ed.), Obesity Assessment: Tools, Methods, Interpretations. New York: Chapman and Hall, 1997.
Dansky BS, Brewerton TD, O’Neil PM, Kilpatrick DG. The nature and prevalence of binge eating disorder in a national sample of women. In TA Widiger, AJ Frances, HA Pincus, MB First, R Roth, W David (Eds.), DSM-IV Sourcebook. Washington: American Psychiatric Association Press, Inc., 1998.
Williamson DA, O’Neil PM. Behavioral and psychological correlates of obesity. In G Bray, C Bouchard (Eds.) Handbook of Obesity, 1998.
Barker SE, O’Neil PM. Anorexia and bulimia nervosa. In AJ Goreczny, M Hersen (Eds.), Handbook of Pediatric and Adolescent Health Psychology. New York: Allyn & Bacon, 1999.
O’Neil PM. The multidisciplinary team in the management of obesity. In DJ Goldstein (Ed.), Management of Eating Disorders and Obesity. Humana Press, 1999.
O’Neil PM. The roles of behaviour modification in the management of obesity. In G Medeiros-Neto, A Halpern, C Bouchard (Eds.), Progress in Obesity Research: 9. Montrouge, France: John Libbey Eurotext, 2003.
23
O’Neil PM, Martin CK. Management of obesity. In BM Egan, JN Basile, DT Lackland (Eds.), Hypertension Hot Topics. Philadelphia: Hanley & Belfus, 2004.
Williamson DA, O’Neil PM. Obesity and quality of life. In G Bray and C Bouchard (Eds.), Handbook of Obesity, Second Edition. New York: Marcel Dekker, Inc., 2004
O’Neil PM & Rieder S. The multidisciplinary team in the management of obesity. In DJ Goldstein (Ed.) The Management of Eating Disorders and Obesity: 2nd Edition. Totowa, NJ: Humana Press, 2005.
Peer Reviewed Electronic Publications:None
Non-Peer Reviewed Electronic Publications:None
Other Publications: O'Neil PM, Currey HS. Determined to lose weight? January's the perfect time to start.
FirstMate (First Federal Savings and Loan Association Customer/Stockholder Newsletter), January 1988.
O'Neil PM. Weight management plans can go back to school. Lean Times, September 1989.
O'Neil PM. How to fight temptation. Lean Times, March 1990.
"Weighing the Choices" column, Charleston, SC Sunday Post and Courier:O'Neil PM. Limited diet won't help you lose more fat, just water and muscle.
August 2, 1987
O'Neil PM. Energy: Right amount can give you a boost, too much causes excessive weight gain. August 9, 1987.
O'Neil PM. Weight loss: Eat less and burn more. August 16, 1987.
O'Neil PM. Reduce eating cues, reduce weight. September 6, 1987.
O'Neil PM. All calories are not equal. September 13, 1987.
O'Neil PM, Malcolm RJ. Are you an apple or a pear? September 20, 1987.
O'Neil PM, Piper GE. What is metabolism? September 27, 1987.
O'Neil PM, Piper GE. Metabolism: A hot subject. October 4, 1987.
O'Neil PM, Hanahan RA. Fiber is an important part of diet. October 11, 1987.
O'Neil PM, Malcolm RJ. Lose excess weight and sleep better. October 18, 1987.
O'Neil PM, Hanahan RA. Dieters can talk themselves into losing extra pounds. October 25, 1987.
24
O'Neil PM, Von JM. Weight control affects body image. November 1, 1987.
O'Neil PM, Piper GE. Passive exercise: you get what you put into it. November 8, 1987.
O'Neil PM. Weight loss seminar brings out findings on “feeding behavior.” November 15, 1987.
O'Neil PM, Hanahan RA. Don't let Thanksgiving meal mark end of your diet plan. November 22, 1987.
O'Neil PM. The jury has no verdict on many weight questions. November 29, 1987.
O'Neil PM, Smith JL. Exercising assertiveness can help control weight. December 6, 1987.
O'Neil PM, Hanahan RA. Calories can be cut without sacrificing quality, taste of foods. December 13, 1987.
O'Neil PM, Currey HS. Holiday season needn't be ruined for those on diets. December 20, 1987.